Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
Pride Special: J&J's Edmond Chan on the value in being your authentic self
J&J’s Edmond Chan discusses how both the pharmaceutical and healthcare industries can do their best to support people from the LGBTQ+ community
Read more
Is medical affairs the Ferrari of the pharma industry?
In this episode, Isabel chats with Bora Erdemli, Associate Principal and Leader of Medical Affairs Practice, Europe, ZS.
Super reps, ChatGPT and pharma’s future on social media
Isabel chats to Darshan Kulkarni, regulatory and compliance attorney for the Life Sciences, about key marketing and medical affairs trends.
Meet GOLD's new catalyst – AZ’s Mina Makar
Helena and Isabel share exclusive clips from the conversation with GOLD’s latest Catalyst interviewee: AstraZeneca’s Mina Makar.
New era for neuroscience and the importance of purpose
Helena and Isabel kick off Season 4 with Janssen’s Kavita Panke, talking all things neuroscience, high performing teams and more!
The 2023 pharma forecast
Join Helena and Isabel in ringing in the 2023 with a special predictions episode. What’s in store for pharma this year?
Pharma review of the year 2022
Helena and Isabel are joined by six guests to round off 2022 and Season 3 with a look back at the key highlights of the past 12 months.
Sales reps, MSLs and the future of CX
In this episode, the team chat to James Harper, Founder and Managing Director, Twentyeightb, about pharma sales, MSLs and more.
Meet GOLD's new catalyst – GSK's John Wahba
Helena and Isabel share an interview with GOLD’s new catalyst John Wahba, Medical Head of the Global Digital Hub, GS
Loading posts...
« Previous
1
…
3
4
5
6
7
…
21
Next »